Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90

Journal Article · · Journal of Biological Chemistry
The hsp90 chaperones govern the function of essential client proteins critical for normal cell function as well as cancer initiation and progression. Hsp90 activity is driven by ATP, which binds to the N-terminal domain and induces large conformational changes that are required for client maturation. Inhibitors targeting the ATP-binding pocket of the N-terminal domain have anticancer effects, but most bind with similar affinity to cytosolic Hsp90α and Hsp90β, endoplasmic reticulum Grp94, and mitochondrial Trap1, the four cellular hsp90 paralogs. Paralog-specific inhibitors may lead to drugs with fewer side effects. The ATP-binding pockets of the four paralogs are flanked by three side pockets, termed sites 1, 2, and 3, which differ between the paralogs in their accessibility to inhibitors. Previous insights into the principles governing access to sites 1 and 2 have resulted in development of paralog-selective inhibitors targeting these sites, but the rules for selective targeting of site 3 are less clear. Earlier studies identified 5'N-ethylcarboxamido adenosine (NECA) as a Grp94-selective ligand. Here we use NECA and its derivatives to probe the properties of site 3. We found that derivatives that lengthen the 5' moiety of NECA improve selectivity for Grp94 over Hsp90α. Crystal structures reveal that the derivatives extend further into site 3 of Grp94 compared with their parent compound and that selectivity is due to paralog-specific differences in ligand pose and ligand-induced conformational strain in the protein. These studies provide a structural basis for Grp94-selective inhibition using site 3.
Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE
Contributing Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
OSTI ID:
1734920
Journal Information:
Journal of Biological Chemistry, Journal Name: Journal of Biological Chemistry Journal Issue: 44 Vol. 294; ISSN 0021-9258
Publisher:
American Society for Biochemistry and Molecular BiologyCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (39)

Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer journal September 2017
5′- N -ethylcarboxamidoadenosine is not a paralog-specific Hsp90 inhibitor: NECA is not a Paralog-specific Hsp90 Inhibitor journal October 2016
Structures of Hsp90α and Hsp90β bound to a purine‐scaffold inhibitor reveal an exploitable residue for drug selectivity journal June 2019
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization journal September 2004
Evolution and function of diverse Hsp90 homologs and cochaperone proteins journal March 2012
Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers journal March 2012
GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum journal March 2012
Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity—Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases journal January 2014
Heat Shock Protein gp96 Is a Master Chaperone for Toll-like Receptors and Is Important in the Innate Function of Macrophages journal February 2007
Structures of GRP94-Nucleotide Complexes Reveal Mechanistic Differences between the hsp90 Chaperones journal October 2007
Structure–Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94 journal April 2015
Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold journal March 2016
Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding journal March 2018
Soluble and membrane-associated human low-affinity adenosine binding protein (adenotin): properties and homology with mammalian and avian stress proteins journal May 1990
Development of a Grp94 inhibitor journal May 2012
Structural and Quantum Chemical Studies of 8-Aryl-sulfanyl Adenine Class Hsp90 Inhibitors journal August 2006
Design, Synthesis, and Biological Evaluation of Hydroquinone Derivatives of 17-Amino-17-demethoxygeldanamycin as Potent, Water-Soluble Inhibitors of Hsp90 journal July 2006
Tricyclic Series of Heat Shock Protein 90 (Hsp90) Inhibitors Part I: Discovery of Tricyclic Imidazo[4,5- c ]pyridines as Potent Inhibitors of the Hsp90 Molecular Chaperone journal October 2011
Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series journal August 2013
Identification of Novel HSP90α/β Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration of Potential Utility in Treating CNS Disorders such as Huntington’s Disease journal April 2014
5‘- N -Substituted Carboxamidoadenosines as Agonists for Adenosine Receptors journal April 1999
The epichaperome is an integrated chaperome network that facilitates tumour survival journal October 2016
Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability journal September 2001
Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2 journal September 2013
HSP90 at the hub of protein homeostasis: emerging mechanistic insights journal June 2010
Adapting to stress — chaperome networks in cancer journal May 2018
Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway journal April 2013
Ligand Interactions in the Adenosine Nucleotide-binding Domain of the Hsp90 Chaperone, GRP94: I. EVIDENCE FOR ALLOSTERIC REGULATION OF LIGAND BINDING journal May 2000
Structure of the N-terminal Domain of GRP94: BASIS FOR LIGAND SPECIFICITY AND REGULATION journal September 2003
Structure of Unliganded GRP94, the Endoplasmic Reticulum Hsp90: BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE journal June 2005
Chaperome heterogeneity and its implications for cancer study and treatment journal November 2018
GRP94 Is Essential for Mesoderm Induction and Muscle Development Because It Regulates Insulin-like Growth Factor Secretion journal October 2007
A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond journal April 2019
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet? journal January 2012
Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma journal September 2013
TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90  and  , Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models journal November 2014
Development of a Fluorescence Polarization Assay for the Molecular Chaperone Hsp90 journal August 2004
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future journal August 2016
Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94 journal August 2016